Blood clotting is a complex process in our body that maintains hemostasis and prevents excessive bleeding. However, in certain medical conditions like surgeries, bleeding disorders, trauma or liver disease, our clotting ability may be impaired putting us at risk of life-threatening bleeding. This is where thromboelastography (TEG) comes into play. TEG is a breakthrough diagnostic tool that evaluates the entire coagulation process in whole blood and helps clinicians better understand and manage bleeding disorders.
What is thromboelastography?
Thromboelastography or TEG is a medical technology that analyzes whole blood coagulation in real-time. It uses a pin suspended in a cuvette which contains citrated whole blood. As the blood sample clots, the pin oscillates and transmits signals on a monitor that form a thromboelastogram tracing the progression of clot formation and breakdown over time. By analyzing various parameters from the tracing like reaction time (R), kinetic time (K), alpha angle (α), and maximum amplitude (MA), TEG provides a comprehensive overview of the coagulation process including clot firmness, rate of fibrin buildup and clot lysis or breakdown.
Conventional coagulation tests like prothrombin time (PT) and activated partial thromboplastin time (aPTT) have limitations as they only assess the initial phases of clotting and do not evaluate clot strength and stability. In contrast, TEG provides a holistic view of hemostasis by measuring the interaction between platelets, fibrinogen and other clotting factors in whole blood. This makes it a powerful diagnostic modality for detecting coagulation abnormalities that cannot always be uncovered by standard coagulation assays.
Importance of TEG in surgical settings
TEG has revolutionized bleeding management in surgery and trauma where rapid diagnosis and tailored treatment of coagulopathies is critical. Conventional tests may not detect acquired coagulation defects due to blood loss, dilution, hypothermia or consumption of clotting factors which commonly occur during surgeries and major trauma. TEG allows clinicians to quickly gauge the severity of these acquired clotting disorders and guide targeted hemostatic therapy, thus preventing life-threatening bleeding episodes.
In cardiac surgery involving cardiopulmonary bypass, TEG helps monitor for heparin-induced coagulopathy during bypass and guides adequate protamine dosage for reversal. It assists appropriate administration of blood products like fresh frozen plasma, platelets, fibrinogen and factor concentrates based on the specific coagulation defect detected on TEG tracing. Numerous studies have reported reduced blood product usage, transfusion requirements and costs with the use of TEG-guided hemostatic therapy in complex surgeries.
Detecting coagulopathies in liver disease
Diseases affecting the liver like cirrhosis and liver failure often impair production of coagulation factors and inhibitors, predisposing affected individuals to bleeding risks. Due to liver synthetic dysfunction, standard coagulation tests may provide misleading results in these conditions. TEG is able to comprehensively measure the balance between hypercoagulable and hypocoagulable states in liver disease, identifying both intrinsic and acquired factor deficiencies. It helps classify the severity of coagulopathy guiding prophylactic strategies and improved perioperative outcomes in liver patients undergoing invasive procedures or surgery. TEG also detects rebalanced hemostasis after initiation of specialized treatment protocols or liver transplantation allowing prompt discontinuation of hemostatic support when indicated.
Potential in trauma resuscitation
Early identification and reversal of trauma-induced coagulopathy is crucial for improved survival of severe trauma victims. Standard tests are not rapid enough to guide initial resuscitation in these emergency situations where every minute counts. TEG allows goal-directed correction of coagulopathy in trauma bays and operating rooms by revealing specific factor or platelet defects as well as monitoring response to substitution of deficient components within minutes of sample analysis. Large observational studies have reported reduced mortality and transfusions when trauma centers apply TEG-guided resuscitation algorithms. TEG helps optimize hemostatic resuscitation during the "golden hour" after injury aiding trauma teams to focus efforts on individualized targeted therapy rather than empirical transfusions.
Future applications
Beyond surgical and trauma settings, TEG has immense scopes of further utility in other hematological and cardiovascular disorders. Researchers are working towards developing TEG based assays to identify bleeding phenotypes in rare congenital bleeding disorders like Glanzmann thrombasthenia, Bernard-Soulier syndrome and platelet function defects. Point-of-care TEG devices are also being evaluated for application in out-of-hospital and pre-hospital emergency care. Studies are ongoing to explore the potential of TEG in predicting thrombosis risk in atrial fibrillation patients and monitoring antiplatelet therapy in vascular disease and coronary artery disease patients. With refinements and expansion to new areas, thromboelastography holds promise to become a routine component of hemostasis evaluation benefitting diverse medical specialties in the future.
In summary, thromboelastography is a breakthrough whole blood coagulation diagnostic tool that overcomes limitations of conventional tests. It provides comprehensive analysis of coagulation from thrombin generation to clot lysis guiding goal-directed management of bleeding disorders in settings like surgery, trauma, liver disease and hematological conditions. With advantages in rapid diagnosis and targeted therapy, TEG has transformed bleeding care protocols worldwide revolutionizing patient outcomes. Further refinements will see this valuable diagnostic modality assume even greater significance helping clinicians deliver evidence-based transfusion practice and individualized hemostatic management across an array of clinical scenarios.
Get more insights on: Thromboelastography
